Claire Thomas
Direttore/Membro del Consiglio presso REBUS HOLDINGS, INC.
Patrimonio netto: - $ in data 31/12/2023
Posizioni attive di Claire Thomas
Società | Posizione | Inizio | Fine |
---|---|---|---|
REBUS HOLDINGS, INC. | Direttore/Membro del Consiglio | 12/10/2016 | - |
Independent Dir/Board Member | 12/10/2016 | - | |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Claire Thomas
Precedenti posizioni note di Claire Thomas
Società | Posizione | Inizio | Fine |
---|---|---|---|
ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31/07/2013 | 30/06/2016 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/08/2008 | 01/01/2013 |
Formazione di Claire Thomas
University of Illinois | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Giappone | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTELLAS PHARMA INC. | Health Technology |
REBUS HOLDINGS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Claire Thomas
- Esperienza